CLINICAL_TRIALS trial_result · 2011-06-21

Clinical Trial Update: Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment [Phase 3]

Phase 3 efficacy and safety results for HZT-501 in patients requiring NSAID therapy for ulcers have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2011-06-21